195 related articles for article (PubMed ID: 9744565)
1. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon.
Amitai G; Moorad D; Adani R; Doctor BP
Biochem Pharmacol; 1998 Aug; 56(3):293-9. PubMed ID: 9744565
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of the in vitro inhibition, aging, and reactivation of brain acetylcholinesterase from rat and channel catfish by paraoxon and chlorpyrifos-oxon.
Carr RL; Chambers JE
Toxicol Appl Pharmacol; 1996 Aug; 139(2):365-73. PubMed ID: 8806854
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hen brain acetylcholinesterase and neurotoxic esterase by chlorpyrifos in vivo and kinetics of inhibition by chlorpyrifos oxon in vitro: application to assessment of neuropathic risk.
Richardson RJ; Moore TB; Kayyali US; Fowke JH; Randall JC
Fundam Appl Toxicol; 1993 Apr; 20(3):273-9. PubMed ID: 7684990
[TBL] [Abstract][Full Text] [Related]
4. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
5. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
6. Inhibition and aging of channel catfish brain acetylcholinesterase following exposure to two phosphorothionate insecticides and their active metabolites.
Carr RL; Straus DL; Chambers JE
J Toxicol Environ Health; 1995 Jul; 45(3):325-36. PubMed ID: 7541841
[TBL] [Abstract][Full Text] [Related]
7. The pH dependence of dealkylation in soman-inhibited cholinesterases and their mutants: further evidence for a push-pull mechanism.
Saxena A; Viragh C; Frazier DS; Kovach IM; Maxwell DM; Lockridge O; Doctor BP
Biochemistry; 1998 Oct; 37(43):15086-96. PubMed ID: 9790671
[TBL] [Abstract][Full Text] [Related]
8. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
Milatovic D; Dettbarn WD
Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
[TBL] [Abstract][Full Text] [Related]
9. Comparative sensitivity of bovine and rodent acetylcholinesterase to in vitro inhibition by organophosphate insecticides.
Cohen SD; Williams RA; Killinger JM; Freudenthal RI
Toxicol Appl Pharmacol; 1985 Dec; 81(3 Pt 1):452-9. PubMed ID: 2417385
[TBL] [Abstract][Full Text] [Related]
10. Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.
Minic J; Chatonnet A; Krejci E; Molgó J
Br J Pharmacol; 2003 Jan; 138(1):177-87. PubMed ID: 12522088
[TBL] [Abstract][Full Text] [Related]
11. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum.
Huff RA; Corcoran JJ; Anderson JK; Abou-Donia MB
J Pharmacol Exp Ther; 1994 Apr; 269(1):329-35. PubMed ID: 7513360
[TBL] [Abstract][Full Text] [Related]
12. Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase.
Berman HA; Leonard K
Mol Pharmacol; 1992 Feb; 41(2):412-8. PubMed ID: 1538717
[TBL] [Abstract][Full Text] [Related]
13. Kinetic analyses of the microsomal biotransformation of the phosphorothioate insecticides chlorpyrifos and parathion.
Sultatos LG; Murphy SD
Fundam Appl Toxicol; 1983; 3(1):16-21. PubMed ID: 6193025
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase protects against chlorpyrifos toxicity in mice.
Li WF; Furlong CE; Costa LG
Toxicol Lett; 1995 Apr; 76(3):219-26. PubMed ID: 7539166
[TBL] [Abstract][Full Text] [Related]
15. Neurobehavioral assessment of mice following repeated postnatal exposure to chlorpyrifos-oxon.
Cole TB; Fisher JC; Burbacher TM; Costa LG; Furlong CE
Neurotoxicol Teratol; 2012; 34(3):311-22. PubMed ID: 22425525
[TBL] [Abstract][Full Text] [Related]
16. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase.
Masson P; Froment MT; Bartels CF; Lockridge O
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):53-61. PubMed ID: 9224629
[TBL] [Abstract][Full Text] [Related]
17. Additive inhibitory action of chlorpyrifos and polycyclic aromatic hydrocarbons on acetylcholinesterase activity in vitro.
Jett DA; Navoa RV; Lyons MA
Toxicol Lett; 1999 Apr; 105(3):223-9. PubMed ID: 10355543
[TBL] [Abstract][Full Text] [Related]
18. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities.
Katz EJ; Cortes VI; Eldefrawi ME; Eldefrawi AT
Toxicol Appl Pharmacol; 1997 Oct; 146(2):227-36. PubMed ID: 9344890
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the in vitro sensitivity of rat acetylcholinesterase to chlorpyrifos-oxon: what do tissue IC50 values represent?
Mortensen SR; Brimijoin S; Hooper MJ; Padilla S
Toxicol Appl Pharmacol; 1998 Jan; 148(1):46-9. PubMed ID: 9465262
[TBL] [Abstract][Full Text] [Related]
20. Cholinesterase inhibitors proposed for treating dementia in Alzheimer's disease: selectivity toward human brain acetylcholinesterase compared with butyrylcholinesterase.
Pacheco G; Palacios-Esquivel R; Moss DE
J Pharmacol Exp Ther; 1995 Aug; 274(2):767-70. PubMed ID: 7636741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
